Clinical assessment of drug-induced disease (Q34084245)

30 July 2017

Clinical assessment of drug-induced disease (English)

1 reference

30 July 2017

R S Gruchalla

1

1 reference

PubMed ID

11081549

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

356

1 reference

30 July 2017

1505-1511

1 reference

30 July 2017

9240

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Allergic reactions to drugs and biologic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Idiosyncratic drug reactions: a mechanistic evaluation of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

In vitro analysis of metabolic predisposition to drug hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

The role of reactive drug metabolites in immune-mediated adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

In vitro evaluation of a toxic metabolite of sulfadiazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

An in vitro lymphocytotoxicity assay for studying adverse reactions to sulphonamides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Mycoplasma pneumoniae infections and Stevens-Johnson syndrome. Report of eight cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Clinical approach to penicillin-allergic patients: a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Evaluation of mast cell activation (tryptase) in two patients suffering from drug-induced hypotensoid reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

Evaluation of skin test reactions in patients with non-immediate type drug eruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902885-3

7 January 2021

10.1016/S0140-6736(00)02885-3

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11081549